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Treatment with ACEI (OR=6.13, p=0.09) and HTA (OR=2.62, p = 0.06) tend
to be positively associated with ARF while a contrast dose above 80 mL tends
to be negatively associated (OR=0.24, p = 0.08).
High dose of contrast administration was associated with low Cl Cr (spearman
correlation coefficient=-0.19, p < 0.03) and decrease of Hb (-1.21, p < 0.02).
 
Conclusion:
 
  Acute renal failure is a frequent and severe complication after
CRT implantation. Careful pre and post implantation management is required.
Mechanism seems more complex than a contrast induced nephropathy. 
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Background: 
 
ICD is an effective treatment to prevent SCD but very long
term follow-up is poorly known
 
Methods: 
 
We retrospectively studied the 67 patients implanted with an
ICD at the University Hospital of Toulouse between 1989 and 1999.
 
Results: 
 
Characteristics of the population are (number of patients): males:
56, ischemic heart disease (IHD): 42, mean EF 42%, secondary prevention:
62, abdominal implantation: 30, dual chamber devices: 57. Data were com-
plete for 58 patients (mean follow-up: 100 months +/- 103), nine patients were
lost to follow up (mean 52 +/- 40 months). Survival rate (of the 58 patients)
is respectively 93%, 71% and 48% at 1, 5 and 10 years.  Cause of death was
cardiac for 10 patients (7 terminal cardiac failures, 2 sudden cardiac deaths
and 1 endocarditis), extra cardiac for 7 patients and unknown for 13. 
Independent factors of global mortality are: age (p=0.038), IHD (p=0.035),
NYHA > 2 (p=0.0058), EF < 35% (p=0.0005). 37 patients experienced appro-
priate ICD therapy, 13 of them suffered an electrical storm. 18 patients pre-
sented with inappropriate therapy (oversensing: 44%, supra ventricular
tachycardia: 39%). Non rhythmic complications occurred in 27 patients (infec-
tions: 4, ICD lead related complications: 7, delay of healing or haematoma:
12).
 
Conclusion: 
 
Patients implanted with ICD before 2000 remain at high risk
of mortality and morbidity.
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Purpose
 
: Chronic right ventricular pacing (VP) has been linked to delete-
rious effect on cardiac function. This registry was designed to quantify the
efficacy of Intrinsic Rhythm Support algorithm (IRS Plus), aimed to minimize
VP.
 
Methods:
 
 Patients (pts) were prospectively included 1 to 3 months after
PM implantation and had IRS Plus set on. Device statistics were collected
after 6 months of FU.
 
Results:
 
 Preliminary results have been obtained in 158 pts (mean age 78±9
years, 55% male). Median VP% was 3.9 in pts with SND vs 25.3 in pts pre-
senting an impaired AV conduction (p=0.024). The median VP% was 4.2 in
pts with normal baseline PR interval vs 39.5 in pts with prolonged (>200 ms)
PR interval (p<0.0001). AF burden was significantly lower in pts with VP%
less or equal to 10% (0.4% vs 4.2%, p=0.026).
 
Conclusion:
 
 IRS Plus reduces unnecessary VP, especially in pts with pure
SND. Avoiding VP appears to decrease AF burden.
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Backgrounds: 
 
Implantable cardioverter-defibrillator (ICD) malfunctions
sometimes need recall. Despite the increasing number of device implantation,
ICD recalls and advisories’ impacts have been little studied. The aim of this
study was to determine the rate of ICD generator advisory in our center and to
examine its clinical and financial implication.
 
Methods: 
 
We
 
 
 
analyzed weekly FDA Enforcement Reports issued between
January 2000 and December 2008 to identify all advisories involving ICD
generators and leads. We performed a retrospective analysis of all implanted
patients affected by an advisory in our Cardiology department.
 
Results: 
 
During the 8 years of the study period, 13 advisories were issued
for generators and 1 for leads, leading to a total number of 278/1051 (26.4%)
device with recall alerts, divided into 196 generator failures and 82 lead fail-
ures. Premature generator replacement was performed in 11 patients whereas
9 patients underwent lead replacement. There was no major complications
attributable to advisory device replacement, and minor complications occurred
only in 1 patient (lead extraction failure). Recalls accounted for 593 extra out-
patient visits with a mean number of 2.20 ± 2.19 per patient. The total esti-
mated cost of the device advisories in our population was 334 528 ı.
 
Conclusions: 
 
ICD recalls and safety alerts frequently occur in ICD recipi-
ents and tend to increase in number and rate. Although potentially serious,
they are not associated with substantial complications. Financial implications
are important.
 
180
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Atrial fibrillation (AF) is a major cause of stroke. AF incidence is increased
in Wolff-Parkinson-White syndrome (WPW), represents about 10 % of spon-
taneous arrhythmias and has several mechanisms as the degeneration of atrio-
ventricular reentrant tachycardia (AVRT) into AF, the AF facilitation by the
atrial insertion of accessory pathway (AP) or another origin. The purpose of
study was to assess the incidence of stroke in patients (pts) who had a preex-
citation syndrome.
 
Population:
 
 707 pts aged from 5 to 85 years (mean 34.5±17) were studied
for a WPW: 93 pts had unexplained syncope; 247 pts were asymptomatic; 367
pts had spontaneous tachycardias; among these pts 52 had documented AF.
Electrophysiological study (EPS) consisted of atrial pacing and programmed
atrial stimulation in control state and if necessary after infusion of isoproter-
enol. Clinical and electrophysiological data were collected.
 
Results:
 
 Stroke was noted in 5 pts (0.7 %), 2 women, 3 men aged from 53
to 75 years. They had a normal carotid and transcranial Doppler ultrasonog-
raphy. One pt had ischemic heart disease and the remaining pts had no heart
disease. Their age was significantly older than remaining population (62±9
years vs 34± 17) (p<0.0002). Only one pt had spontaneous AF; 51 other pts
with spontaneous AF had no stroke. One of 247 was asymptomatic; one pt of
93 had syncope and 2 pts of 315 had spontaneous AVRT. At EPS, one asymp-
tomatic pt had AP with long refractory period and no inducible tachycardia.
Two pts with spontaneous tachycardias had only inducible AVRT and the pt
with spontaneous AF had inducible antidromic tachycardia and AF. The pt
with syncope had only inducible AF. These electrophysiological data did not
differ from the remaining population. Anticoagulants were maintained after
AP ablation, although the disappearance of arrhythymias.
